

Cardiology Update
Inflammation as predictor of future cardiovascular event risk
/
RSS Feed
Both inflammation and hyperlipidemia contribute to cardiovascular disease. However in patients receiving statin therapy the relative contributions of inflammation and hyperlipidemia to future CV risk can change. As a result, this has implications on adjunctive therapy choice.
In this episode, Dr. Chadi Alraies discusses a recent study that evaluated high sensitivity CRP and LDL-C as predictors of cardiovascular event risk in patients on statin therapy.
For more cardiology research news join our newsletter or follow us on Twitter, Facebook, LinkedIn or Instagram.
Original article: Ridker PM et al. Lancet. 2023 Mar 3;S0140-6736(23)00215-5.